Hexylresorcinol

05/01/1951 - "[Application of hexylresorcinol in the treatment of ascaridosis and trichocephaliasis in children]."
01/01/1951 - "[Hexylresorcinol in the treatment of rectal trichocephaliasis]."
01/01/1952 - "[Treatment of trichocephaliasis with hexylresorcinol (santokin) in a form of enema; report of four cured cases]."
09/01/1951 - "[Nine cases of trichocephaliasis cured with hexylresorcinol enemas (santokin)]."
09/01/1951 - "[One hundred cases of trichocephaliasis cured with hexylresorcinol enemas (santokin)]."

02/24/2020 - "In conclusion, in vitro data indicate that hexylresorcinol lozenges offer rapid bactericidal activity against organisms implicated in acute sore throat."
02/24/2020 - "Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat."
02/24/2020 - "This study evaluated the in vitro bactericidal activity of lozenges containing the antiseptic hexylresorcinol against five bacteria associated with acute sore throat: Staphylococcus aureus, Streptococcus pyogenes, Moraxella catarrhalis, Haemophilus influenzae and Fusobacterium necrophorum. "
11/01/2015 - "Lozenges containing amylmetacresol and 2,4-dichlorobenzyl alcohol (AMC/DCBA lozenges) as well as lozenges containing hexylresorcinol have been shown to provide effective symptomatic relief for sore throat. "
01/01/2012 - "Both AMC/DCBA + lidocaine and hexylresorcinol lozenges provided rapid and effective sore throat relief in patients with URTI."

11/01/2015 - "These findings suggest that AMC/DCBA lozenge and hexylresorcinol lozenge have the potential to have local antiviral effects in patients with sore throat due to viral respiratory tract infections. "
01/01/2012 - "Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection."
01/01/2012 - "This study was conducted to determine the analgesic efficacy of two lozenges one containing amylmetacresol (AMC)/2,4-dichlorobenzyl alcohol (DCBA) and lidocaine and one containing hexylresorcinol  versus placebo in patients with acute sore throat due to upper respiratory tract infection (URTI). "

05/01/1954 - "[Comparative efficacy of hexylresorcinol and of a mixture of tetrachloroethylene and chenopodium in the treatment of intestinal helminthiasis]."

02/01/1998 - "Studies were performed on the efficacy, residues and in vitro enterocyte toxicity of 4-hexylresorcinol (4-HR), which could be utilized as an inhibitor of shrimp melanosis (black spot). "
02/01/1998 - "4-Hexylresorcinol as inhibitor of shrimp melanosis: efficacy and residues studies; evaluation of possible toxic effect in a human intestinal in vitro model (Caco-2); preliminary safety assessment."
10/01/1991 - "These studies, along with the aforementioned data, demonstrate that 4-hexylresorcinol presents no risk of toxicity at the levels proposed for treatment of shrimp, and the use of 4-hexylresorcinol as a processing aid to prevent melanosis in shrimp is GRAS."
04/01/2008 - "White shrimp pretreated with 4-hexylresorcinol had the lower melanosis throughout the storage compared with those without treatment (P < 0.05). "
03/01/1998 - "4-Hexylresorcinol is used to prevent melanosis in shrimp, and the same use has been proposed for crab meat. "